Sheep Study Links Semaglutide to Reduced Fetal Blood Flow and Oxygen
Researchers observed reduced uterine blood flow and lower fetal oxygen levels within two hours of dosing in pregnant sheep.
What the University of Adelaide Study Measured
Researchers at the University of Adelaide evaluated how semaglutide affects maternal circulation and fetal oxygenation in pregnant sheep.
S. Cho and colleagues published their findings as a conference abstract in the journal Heart, Lung and Circulation. The team focused on late gestation. They administered semaglutide to pregnant sheep while tracking cardiovascular responses.
Advanced magnetic resonance imaging (MRI) measured maternal heart function and blood flow to the uterus before and after drug administration. Researchers collected fetal blood samples and tracked fetal heart rate and blood pressure to detect immediate circulatory changes.
Blood Flow and Oxygen Levels Fell within Two Hours
Semaglutide administration led to measurable reductions in maternal blood output and fetal oxygen levels within two hours.
The amount of blood pumped by the maternal heart decreased following the dose. This drop restricted uterine perfusion. Lower blood flow to the uterus subsequently reduced the oxygen concentration measured in fetal blood.
Adelaide University researcher Dr. Mitchell Lock noted that steady oxygen delivery is necessary for fetal development. A sudden drop in oxygen raises concerns about repeated drug exposure across gestation.
Current Medical Guidance on Semaglutide during Pregnancy
Current clinical guidelines advise against using semaglutide during pregnancy and recommend stopping the drug before conception.
Medications that mimic glucagon-like peptide-1 (GLP-1) have grown common for weight management and diabetes care. Roughly 12 percent of adults in the United States currently take GLP-1 medications. In Australia, around half a million individuals use them for diabetes.
Weight reduction often improves fertility, which can lead to unexpected pregnancies while a woman is still taking the medication. Patients managing blood sugar often face difficult treatment choices when considering pregnancy.
Study Limitations and Unresolved Questions in Humans
These animal findings remain preliminary and do not establish whether identical circulatory reductions occur in human pregnancies.
Senior researcher Janna Morrison noted that the study only evaluated immediate changes. The researchers did not determine if temporary oxygen drops impair long-term fetal growth. Sheep cardiovascular systems differ from human physiology in several ways.
Further clinical investigations are necessary before healthcare providers can understand the true risks of prolonged exposure during human gestation.
What to Look For in a Body-Composition Scale
A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.


Related Articles
Type 1 Diabetes Score Misses Remissions in Youth with Obesity
A Diabetes Care study finds insulin dose-adjusted hemoglobin A1c (IDAA1c) misses over half of...
Read article MetabolismStudy Finds Widening Disparities in Weight-Loss GLP-1 Access
A study of 512,389 commercially insured adults found that access gaps for weight-loss GLP-1...
Read article MetabolismGlucose-Powered Implant Improves Blood Sugar in Animal Study
A study in Nature reports on NeuroAxis, an experimental implant powered by glucose that...
Read article MetabolismNatural Peptide Protects Retinal Cells in Laboratory Diabetes Model
A study in Biomedicine & Pharmacotherapy shows the Annexin A1 peptide Ac2-26 shields retinal...
Read articleWant medical weight loss instead of another diet?
Opt Health prescribes and monitors GLP-1 therapy against real labs — insulin, A1C, lipids, thyroid, hormones — so the plan fits your physiology rather than a generic protocol. Medication ships to your door.
See Opt Health's weight-loss program →Topic updates
Get the weekly metabolic health roundup
Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.
Understand Your Health Better
Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results
Affiliate disclosure: The Metabolic Journal is reader-supported. Some links above are affiliate or referral links and we may earn a commission at no extra cost to you. Products are chosen on the merits; commissions never influence what we recommend. This is general information, not medical advice — talk to your clinician before acting.